Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)

Historical Holders from Q2 2020 to Q4 2025

Symbol
ORIC on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
98,489,676
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
106,492,098
Holdings value
$1,277,897,890
% of all portfolios
0%
Number of holders
151
Number of buys
89
Number of sells
56
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 10% +8.8% $89,563,080 +$22,127,178 8,729,345 +33% VIKING GLOBAL INVESTORS LP 30 Jun 2025
Nextech Crossover I GP S.a r.l. 8.4% $73,488,656 7,162,637 Nextech Crossover I GP S.a. r.l. 30 Jun 2025
EcoR1 Capital, LLC 6.9% $35,726,296 6,728,116 EcoR1 Capital, LLC 29 Jul 2025
Venrock Healthcare Capital Partners III, L.P. 7.7% +64% $35,029,459 +$18,130,241 6,596,885 +107% Venrock Healthcare Capital Partners III, L.P. 08 Apr 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.8% -13% $47,353,840 4,615,384 0% SR One Capital Management, LLC 12 Aug 2025
ALKEON CAPITAL MANAGEMENT LLC 4.6% $54,049,152 4,504,096 Alkeon Capital Management LLC 30 Sep 2025
Point72 Asset Management, L.P. 5.1% $45,161,021 4,401,659 Point72 Asset Management, L.P. 29 May 2025
COLUMN GROUP II, LP 3.7% $48,612,534 3,644,118 Peter Svennilson 30 Sep 2025
BlackRock, Inc. 4.2% $19,223,389 3,620,224 BlackRock, Inc. 30 Jun 2025
FMR LLC 3.5% $12,141,619 2,467,809 FMR LLC 31 Dec 2024
Frazier Life Sciences Public Fund, L.P. 2% $6,938,150 1,410,193 James N. Topper 31 Mar 2025
As of 30 Sep 2025 Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 106,492,098 shares of the company stock as of 30 Sep 2025.

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 503 $4,115 +$761 $8.18 1
2025 Q3 106,492,098 $1,277,897,890 +$159,719,073 $12.00 151
2025 Q2 93,349,298 $947,499,065 +$169,716,846 $10.15 140
2025 Q1 79,209,337 $442,005,240 +$11,923,653 $5.58 142
2024 Q4 75,794,185 $611,682,286 -$16,308,142 $8.07 129
2024 Q3 69,823,199 $715,076,222 +$22,599,735 $10.25 121
2024 Q2 67,581,249 $477,801,725 +$16,918,129 $7.07 111
2024 Q1 61,522,206 $845,930,302 +$182,999,091 $13.75 93
2023 Q4 16,457 $151,404 -$189,662 $9.20 1
2023 Q3 48,053,106 $290,723,330 +$14,140,743 $6.05 89
2023 Q2 45,537,877 $353,374,807 +$99,053,472 $7.76 83
2023 Q1 33,075,099 $188,527,951 +$3,379,925 $5.70 70
2022 Q4 32,430,291 $192,141,081 -$463,484 $5.89 64
2022 Q3 32,701,288 $104,643,704 -$1,676,650 $3.20 69
2022 Q2 32,836,960 $147,125,000 -$5,569,766 $4.48 75
2022 Q1 31,462,589 $167,970,917 -$6,985,117 $5.34 91
2021 Q4 32,408,019 $476,115,938 -$54,519,859 $14.70 75
2021 Q3 36,405,513 $761,744,855 +$8,529,738 $20.91 80
2021 Q2 36,145,561 $639,409,737 -$3,016,892 $17.69 78
2021 Q1 34,481,967 $844,794,848 +$63,249,843 $24.50 81
2020 Q4 32,486,547 $1,099,708,951 +$273,809,943 $33.85 74
2020 Q3 22,151,946 $552,858,000 +$7,639,740 $25.01 52
2020 Q2 21,388,813 $718,339,063 +$718,339,299 $33.73 64